GSK · GSK
Latest news, signals, and AI analysis for GSK (GSK) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent GSK News
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment - Slideshow
GSK’s bepirovirsen achieves 19% functional cure in hepatitis B trial
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo NordiskFrequently Asked Questions
What sector does GSK belong to?
GSK (GSK) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time GSK news?
Catalayer aggregates GSK coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/GSK.
How fast are GSK news alerts on Catalayer?
News is polled every 30–60 seconds. GSK-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for GSK?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every GSK story.
Is GSK covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support GSK. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.